BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Guvenir M, Arikan A. Hepatitis B Virus: From Diagnosis to Treatment. Pol J Microbiol 2020;69:391-9. [PMID: 33574867 DOI: 10.33073/pjm-2020-044] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang C, Liu W, Zhao X, Zhao L, Wang F. Downregulation of HBx Restrains Proliferation, Migration, and Invasion of HepG2 Cells. Anal Cell Pathol (Amst) 2021;2021:6615979. [PMID: 34094815 DOI: 10.1155/2021/6615979] [Reference Citation Analysis]
2 Dart A, Roy D, Vlaskin V, Limqueco E, Lowe NM, Srinivasan S, Ratner DM, Bhave M, Stayton P, Kingshott P. A nanofiber based antiviral (TAF) prodrug delivery system. Mater Sci Eng C Mater Biol Appl 2022;:112626. [PMID: 35039198 DOI: 10.1016/j.msec.2021.112626] [Reference Citation Analysis]
3 Youssry S, Shalaby T, Maher AS, Ghoneim H. Association of hepatitis B vaccine response to vitamin D supplementation and ultraviolet B (UVB) exposure during different time intervals in experimental animals. Immunol Res 2022. [PMID: 35585421 DOI: 10.1007/s12026-022-09287-8] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ghenea AE, Pădureanu V, Cioboată R, Udriștoiu AL, Drocaş AI, Țieranu E, Carsote M, Vasile CM, Moroşanu A, Biciușcă V, Salan AI, Turculeanu A, Ungureanu A. The Study of Clinical and Biochemical Parameters in Assessing the Response to the Antiviral Therapy in the Chronic Viral Hepatitis B. Medicina (Kaunas) 2021;57:757. [PMID: 34440963 DOI: 10.3390/medicina57080757] [Reference Citation Analysis]